Daiichi Sankyo's Japan Research Foundation for Clinical Pharmacology 11th Annual Clinical Pharmacology Research Award

Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kazunori Hirokawa), has awarded its 11th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 20, 2018.


*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 11th Japan Research Foundation for Clinical Pharmacology Research Award

 

Recipient

Organization

Research theme

Ando Tomoaki

Riken, Center for Integrative Medical Sciences / Atopy Research Center, Graduate School of Medicine, Juntendo University

New therapeutic approach targeting histamine-releasing factor (HRF) as a food allergy amplifier/indicator

Izumi Daisuke

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences

Effects of direct oral anticoagulants at the peak and trough phases, and after vascular injury

Iwao Takahiro

Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University

Generation of human iPS cell-derived intestinal cells for use as pharmacokinetic and toxicokinetic evaluation systems

Ono Masahiro

Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University

Development of SPECT imaging probes targeting tau in Alzheimer’s disease

Kusuhara Hiroyuki

Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo

Development of evaluation method for the potential of OATP1B-mediated DDI using endogenous compounds